Evolus, Inc. Common Stock revenue for the last year amounted to 202.09 M USD, the most of which — 199.72 M USD — came from its highest performing source at the moment, Cash-pay Aesthetic Product, the year earlier bringing 146.59 M USD. The greatest contribution to the revenue figure was made by United States and Europe — last year it brought Evolus, Inc. Common Stock 199.72 M USD, and the year before that — 146.59 M USD.